Antiphospholipid antibodies
Aus coViki
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{tp|p=32268022|t=ä. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 |pdf=|usr=}} {{tp|p=32324958|t=2020. Lupus anticoagulant is freque…“) |
|||
| Zeile 4: | Zeile 4: | ||
{{tp|p=32379918|t=2020. Coagulopathy of COVID-19 and antiphospholipid antibodies |pdf=|usr=}} | {{tp|p=32379918|t=2020. Coagulopathy of COVID-19 and antiphospholipid antibodies |pdf=|usr=}} | ||
{{tp|p=32369280|t=ä. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 |pdf=|usr=}} | {{tp|p=32369280|t=ä. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 |pdf=|usr=}} | ||
| + | {{tp|p=32462425|t=2020. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.|pdf=|usr=008}} | ||
Aktuelle Version vom 27. Juni 2020, 09:08 Uhr
32268022 ä. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
32324958 2020. Lupus anticoagulant is frequent in patients with Covid-19
32379935 2020. Response to "Lupus anticoagulant is frequent in patients with Covid-19"
32379918 2020. Coagulopathy of COVID-19 and antiphospholipid antibodies
32369280 ä. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
32462425 2020. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
